In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 15456-86-7, name is 4-Bromo-1,2-dihydropyridazine-3,6-dione, introducing its new discovery. COA of Formula: C4H3BrN2O2
TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 15456-86-7, and how the biochemistry of the body works.COA of Formula: C4H3BrN2O2
Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N2788 – PubChem